Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland: A 2022 Survey

Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland: A 2022 Survey

Venetoclax, the best established BH3-mimetic, is a practice-changing proapoptotic drug in blood cancers in adults. In paediatrics the data are fewer but exciting results were recently presented in relapsed or refractory leukaemias demonstrating significant clinical activity. Importantly, the in-terv...

Full description

Bibliographic Details
Main Authors: Katarzyna Bobeff, Agata Pastorczak, Zuzanna Urbanska, Walentyna Balwierz, Edyta Juraszewska, Jacek Wachowiak, Katarzyna Derwich, Magdalena Samborska, Krzysztof Kalwak, Iwona Dachowska-Kalwak, Paweł Laguna, Iwona Malinowska, Katarzyna Smalisz, Jolanta Gozdzik, Aleksandra Oszer, Bartosz Urbanski, Maciej Zdunek, Tomasz Szczepanski, Wojciech Mlynarski, Szymon Janczar
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Children
Subjects:
venetoclax
ABT-199
BH3 mimetics
acute lymphoblastic leukaemia
acute myeloid leukaemia
juvenile myelomonocytic leukaemia
Online Access:https://www.mdpi.com/2227-9067/10/4/745

Internet

https://www.mdpi.com/2227-9067/10/4/745

Similar Items